US boosts Technegas sales for Cyclopharm
Radiopharmaceutical manufacturer Cyclopharm has announced unaudited FY23 revenue up 14 percent to $28.9 million and increasing momentum in the roll out of its Technegas lung imaging technology in the United States. The US launch has resulted in 80 issued contracts to date, covering more than 280 individual institutions, of which six are at the final…
Details










